SurgiVision

Since our inception in 1998, SurgiVision has been a leader in pioneering research and development in the field of interventional MRI. Our core technology grew from discoveries in the mid 1990s by researchers working at The Johns Hopkins University. In 1998, SurgiVision was formed to license those technologies from Johns Hopkins and to create a commercial vehicle for on-going development. From 1998 to 2002, we deployed significant resources to fund research and product development. SurgiVision also filed numerous patent applications, submitted filings for and received multiple FDA clearances, and achieved interoperability on MRI magnets from major MRI manufacturers.

Numerous foundational capabilities that form the backbone for enabling MRI-guided interventions were developed during this early period. Broadly, those capabilities include:

• real-time tracking and visualization of coils inside the body;
• high resolution imaging capability of target regions within the body;
• incorporation of diagnostic transducers to measure various parameters;
• incorporation of therapeutic transducers, carriers and needles to deliver therapeutic agents or energy to a target region within the body; and
• the creation of proprietary solutions to the significant issues of heating, patient safety and interference concerns that arise in connection with all MRI-guided interventions.